InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Adams Eric A, 董事长兼首席执行官. Insider active across 1 company, notably InMed Pharmaceuticals Inc.. Cumulatively, 5 disclosures have been recorded. Split: 5 buys · 0 sell. Total volume traded: €62k. Activity tracked since 28 September 2021. The latest transaction was filed on 20 February 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Eric A. Adams is the President & CEO of InMed Pharmaceuticals Inc. He oversees the company's operations and is responsible for the overall strategy. With a strong background in the pharmaceutical sector, Eric A. Adams is committed to advancing InMed Pharmaceuticals Inc.'s initiatives to develop innovative treatments.